about
Proteoglycan form and function: A comprehensive nomenclature of proteoglycansMarine Origin Polysaccharides in Drug Delivery Systems.The Impact of the Low Molecular Weight Heparin Tinzaparin on the Sensitization of Cisplatin-Resistant Ovarian Cancers-Preclinical In Vivo Evaluation in Xenograft Tumor Models.Activation of the transforming growth factor-β/SMAD transcriptional pathway underlies a novel tumor-promoting role of sulfatase 1 in hepatocellular carcinoma.Diversity of heparan sulfate and HSV entry: basic understanding and treatment strategies.A Heparan Sulfate-Binding Cell Penetrating Peptide for Tumor Targeting and Migration Inhibition.GAG-ID: Heparan Sulfate (HS) and Heparin Glycosaminoglycan High-Throughput Identification Software.Syndecan-1 deficiency promotes tumor growth in a murine model of colitis-induced colon carcinomaElevated heparanase expression is associated with poor prognosis in breast cancer: a study based on systematic review and TCGA data.Antiangiogenic platinum through glycan targeting.Achieving high signal-to-noise in cell regulatory systems: Spatial organization of multiprotein transmembrane assemblies of FGFR and MET receptors.Epitope mapping by a Wnt-blocking antibody: evidence of the Wnt binding domain in heparan sulfate.Tissue-specificity of heparan sulfate biosynthetic machinery in cancer.Oncogene-directed alterations in cancer cell metabolism.Antitumor efficacy of the heparan sulfate mimic roneparstat (SST0001) against sarcoma models involves multi-target inhibition of receptor tyrosine kinases.Alteration of colonic epithelial cell differentiation in mice deficient for glucosaminyl N-deacetylase/N-sulfotransferase 4.A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer.NKp44 and Natural Cytotoxicity Receptors as Damage-Associated Molecular Pattern Recognition Receptors.Medical application of glycosaminoglycans: a review.Targeting heparin and heparan sulfate protein interactions.GPC5, a novel epigenetically silenced tumor suppressor, inhibits tumor growth by suppressing Wnt/β-catenin signaling in lung adenocarcinoma.Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate.Dually modified transmembrane proteoglycans in development and disease.A Multivariate Mixture Model to Estimate the Accuracy of Glycosaminoglycan Identifications Made by Tandem Mass Spectrometry (MS/MS) and Database Search.The nature of the conserved basic amino acid sequences found among 437 heparin binding proteins determined by network analysis.Negative Electron Transfer Dissociation Sequencing of 3-O-Sulfation-Containing Heparan Sulfate Oligosaccharides.CTGF/VEGFA-activated fibroblasts promote tumor migration through micro-environmental modulation.The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells.Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-Sulfotransferase
P2860
Q21710680-9BDB0D94-19CE-43BE-B599-F43585554B10Q26767227-A4ACF17B-14B4-4EEE-9AF7-0BA031ACDDCAQ30313205-6FE2AA05-652F-4A99-BD77-B821DF1CCE21Q35224629-73297D5A-66E0-41A1-827F-57115E841D52Q35558287-05BBB1F3-BD15-4AFA-8368-081FC4E32818Q35612443-34A40E05-F91E-4B97-9D42-00810A8DEB67Q35692155-3B24C759-5220-485F-A8C8-A883BBEE380CQ36325314-CF218CC7-E7A7-4B10-B7BF-BE2A5EC4DBB0Q36339725-D5426EC3-CC1D-4498-B4AD-121EB46BA368Q36357296-9F9132D8-1548-436F-8774-62D0D7491803Q36798972-7E87E93E-DBFD-4C45-BD7E-2D92C0BF40A6Q36906823-31CA50BE-8C27-48B8-81BE-20942AA96A2CQ37114695-149511EB-CC84-4E9B-8638-E66AB2FB0266Q37395416-81003823-30D4-48C4-971E-D102F73B5ACFQ37565298-AD11E4B2-3946-4701-A6BF-F9625218A479Q37709048-47977618-5D2A-4702-BE3A-F405FE1A5F23Q37744279-544A268D-6037-4F97-B59C-07D19264CF26Q38362633-8605E942-F919-444D-92CF-C0854EF81B92Q39083233-7A26D95A-F98E-42DF-9E5A-96937991AA4CQ39399937-80C05E62-4004-41D9-B447-04C744F1B111Q40764161-D1D35430-1706-4C43-907E-FB2DA724B74BQ47128720-966DA5B0-2E2A-4E50-954C-1E005EFA8F3DQ47240245-61EA8E94-6B29-44A3-BC38-A5A1794B0FA7Q49733277-B72AC1EB-EB82-4CCD-B3C5-B8DC2E7FE4B8Q51093987-9723FC69-604E-49F3-8A30-37E15E06DFD5Q52346784-5CCB4160-CA64-4F89-9073-64DD136D3FAFQ52579822-E5FD3E58-CCF0-4A37-BD30-22C6E837E822Q55318767-C7CA6210-7B9B-4158-AA5F-9B4BFFCB5CDDQ56395838-87189D9A-EAF2-432C-9EDF-1DB43439DB47
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Heparan sulfate signaling in cancer
@ast
Heparan sulfate signaling in cancer
@en
Heparan sulfate signaling in cancer
@nl
type
label
Heparan sulfate signaling in cancer
@ast
Heparan sulfate signaling in cancer
@en
Heparan sulfate signaling in cancer
@nl
prefLabel
Heparan sulfate signaling in cancer
@ast
Heparan sulfate signaling in cancer
@en
Heparan sulfate signaling in cancer
@nl
P2860
P3181
P1476
Heparan sulfate signaling in cancer
@en
P2093
Gerard C Blobe
Jasmine C Nee
P2860
P304
P3181
P356
10.1016/J.TIBS.2014.03.001
P407
P577
2014-06-01T00:00:00Z